Dallah Healthcare Company (TADAWUL:4004)

Market Cap	11.59B -14.5%
Revenue (ttm)	4.07B +26.9%
Net Income	538.27M +14.2%
EPS	5.32 +10.1%
Shares Out	101.10M
PE Ratio	21.54
Forward PE	17.44
Dividend	2.00 (1.75%)
Ex-Dividend Date	Mar 25, 2026

Volume	106,668
Average Volume	256,192
Open	116.00
Previous Close	116.00
Day's Range	112.50 - 116.00
52-Week Range	90.00 - 157.30
Beta	-0.05
RSI	53.85
Earnings Date	May 21, 2026

About Dallah Healthcare Company

Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, medical centres, complexes, and clinics; and the provision of manpower and support services. It also offers pharmaceuticals, cosmetics, consumables, equipment, and nutritional supplements, as well as medications, diagnostics, and medical technologies. In addition, the company provides personalized treatment plans, post-surgical recovery and chronic ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1987
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4004

Financial Performance

In 2025, Dallah Healthcare Company's revenue was 4.07 billion, an increase of 26.86% compared to the previous year's 3.21 billion. Earnings were 538.27 million, an increase of 14.23%.